Integrated Strategy for Hit-to-Lead Optimization: The ‘DOTS’ approach

webinar

Thu, 27 Oct 2022, 16:00 CEST (Berlin)

Dr. Xavier Morelli, Centre de Recherche en Cancérologie de Marseille (CRCM), France

Integrated Strategy for Hit-to-Lead Optimization: The ‘DOTS’ approach

In recent decades, the identification of hits has been greatly facilitated by advances in high throughput screening (HTS) and the design of chemical libraries. It would be wishful to optimize the automation of the ‘hit-to-lead’ (H2L) process. Xavier will present an integrated strategy for the H2L optimization phase and the automated design of chemical probes called Diversity Oriented Target-Focused Synthesis (DOTS and CovaDOTS) approach.
In the ‘DOTS’ approach, a focused virtual library is generated by combining an activated fragment — corresponding to a substructure that binds to a target — with a collection of functionalized chemical blocks, using in silico encoded relevant chemical reactions. Target-specific compounds are selected by virtual screening, followed by in vitro synthesis and evaluation using a robotic platform. The proof of concept was successfully completed by the optimization of bromodomain inhibitors that lead to the validation of several compounds with an affinity that had improved by several orders of magnitude. The proposed process can be implemented in academic environments or biotechnology companies that desire an automation of these processes.

 

Register and tune in for a very exciting webinar.

1 Hoffer L. et al. J. Med. Chem. 2018 Jul 12;61(13):5719-5732; Carrasco K. et al., J. Med. Chem. 2022 Apr 14;65(7):5660-5674 

2 Hoffer L., et al. J. Chem. Inf. Model. 2019 2019 Apr 22;59(4):1472-1485

Current news

category
Events
Workshop: Next Generation of Compound Catalogs: Trillion-Sized eXplore Chemical Space @ San Diego
April 1, 2025 16:00 CEST
We are excited to announce a collaborative workshop between BioSolveIT and eMolecules, focusing on the Trillion-Sized eXplore Chemical Space. This hands-on session is designed for drug discovery enthusiasts eager to dive into the vast potential of ultra-large compound collections.​ Event Details: Date: Tuesday, April 15, 2025​ Time: 5:00 PM –...
Read on
Enamine’s REAL Space March 2025 Update - Now 76 Billion!
March 27, 2025 13:00 CET
The March 2025 update of Enamine’s REAL Space brings a new expansion — now featuring over 76 billion accessible, drug-like products, up from 70 billion in the previous release. With 172 curated reactions and 182,038 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
CHEMriya Space Update: 55 Billion Molecules Unlocking New Frontiers in Drug Discovery!
March 13, 2025 14:00 CET
We are excited to announce a major update to OTAVA’s CHEMriya™ Chemical Space, now featuring 55 billion accessible molecules built upon 323 in-house reactions. With the March 2025 update, several new reactions have been added to the chemistry portfolio, expanding the space by over 43 billion novel molecules. This significant...
Read on